Full Text
PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis

Abstract

Authors

I. Zimmermann R.E. Schneiders M. Mosca R.F. Alexandre J.M. do Nascimento C.A. Gadelha

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×